Home⇛The PCMC Journal⇛vol. 20 no. 1 (2024)

Efficacy of intranasal Dexmedetomidine in combination with Ketamine as premedication and sedation in pediatric patients: a systematic review and meta-analysis

Cristina Marides L Quijano | Kryzia June B Balneg

Discipline: medicine by specialism

 

Abstract:

OBJECTIVE: To compare the efficacy and safety of the combination of Dexmedetomidine (Dex) and Ketamine (Ket) administered via the intranasal (IN) route on sedation of children aged 0 to 12 years old prior to elective surgery or procedural sedation as compared to Intranasal Dexmedetomidine. METHOD: Relevant studies were identified after a literature search on electronic databases as PubMed, Cochrane Library, Google Scholar and Science Direct. Meta-analyses of mean differences were performed to examine differences in sedation onset and recovery times between IN Dex-Ket and IN Dex. Meta-analyses of proportions were performed to estimate the incidence of sedation success, satisfactory sedation at parental separation and mask induction, and incidence of adverse events. Review Manager 5.4.1 was used for statistical analysis. RESULT: Six articles (388 patients) were included. The overall incidence of sedation success was higher among children premedicated with IN Dex-Ket (RR = 1.05; 95%CI = 0.97,1.13; P = 0.27, I2 = 20%) however was not statistically significant. Children given IN Dex-Ket had faster sedation onset time (WMD = -7.17; 95%CI = -12.44, -1.89; P=0.008) with greater incidence of satisfactory sedation at mask induction (RR = 0.71; 95%CI = 0.53, 0.94; P = 0.02). There was no significant difference as to recovery time and incidence of adverse events among the groups. CONCLUSION: Premedication with IN Dex-Ket is as safe as IN Dex but of better efficacy as evidenced by faster sedation onset time and smoother inhalational induction without increasing clinically relevant adverse events.



References:

  1. Kain Z, Caldwell-Andrews A, Maranets I, Mcclain B, Mayes LC, et al. Preoperative anxiety and emergence delirium and postoperative maladaptive behaviors. Anesth Analg 2004; 99:1648-1654
  2. Mahmoud M, Mason KP. Dexmedetomidine: review, update, and future considerations of paediatric perioperative and periprocedural applications and limitations. Br J Anaesth. 2015 Aug;115(2):171-82. doi: 10.1093/bja/aev226. PMID: 26170346.
  3. Ebert TJ, Hall JE, Barney JA, Uhrich TD, Colinco MD. The effects of increasing plasma concentrations of dexmedetomidine in humans. Anesthesiology 2000;  93:  382– 94.
  4. Lin R, Ansermino JM. Dexmedetomidine in paediatric anaesthesia. BJA Educ. 2020 Oct;20(10):348-353.
  5. Li A., Yuen V.M., Goulay-Dufaÿ S. Pharmacokinetic and pharmacodynamic study of intranasal and intravenous dexmedetomidine. Br J Anaesth. 2018;120:960–968.
  6. Anntila M, Penttila J, Helminen A, Vuorilehto L, Scheinin H. Bioavailability of dexmedetomidine after extravascular doses in healthy subjects. Br J Clin Pharmacol 2003; 56:69-3.
  7. Tervonen M, Pokka T, Kallio M, Peltoniemi O. Systematic review and meta-analysis found that intranasal dexmedetomidine was a safe and effective sedative drug during paediatric procedural sedation. Acta Paediatr. 2020 Oct;109(10):2008-2016
  8. Jun J.H., Kim K.N., Kim J.Y., Song S.M. The effects of intranasal dexmedetomidine premedication in children: a systematic review and meta-analysis. Can J Anesth. 2017;64:947–961.
  9. Ebert TJ, Hall JE, Barney JA, et al. The effects of increasing plasma concentrations of dexmedetomidine in humans. Anesthesiology. 2000;93:382–394
  10. Mason K.P., Zurakowski D., Zgleszewski S.E. High dose dexmedetomidine as the sole sedative for pediatric MRI. Paediatr Anaesth. 2008;18:403–411
  11. Miller, J.W., Divanovic, A.A., Hossain, M.M. et al. Dosing and efficacy of intranasal dexmedetomidine sedation for pediatric transthoracic echocardiography: a retrospective study. Can J Anesth/J Can Anesth 63, 834–841 (2016).
  12. Tsze, D.S., Steele D.W., Machan, J.T.,Akhlaghi, F. and Linakis, J.G.Intranasal Ketamine for Procedural Sedation in Pediatric Laceration Repair: A Preliminary Report. Pediatr. Emerg. Care 2012; 28(8): 767-770
  13. Scheier, E, Siman A and Balla . Intranasal Ketamine Proved Feasible for Pain Control in Paediatric Care and parental Support was High.Acta Paediatr.  2017; 106:1702
  14. Diaz JH. Intranasal ketamine preinduction of paediatric outpatients. Paediatr Anaesth1997;7:273-8.
  15. White PF, Way WL, Trevor AJ. Ketamine–its pharmacology and therapeutic uses.Anesthesiology 1982;56:119-36.
  16. Liu J, Du M, Liu L, et al. Sedation effects of intranasal dexmedetomidine combined with ketamine and risk factors for sedation failure in young children during transthoracic echocardiography. Paediatr Anaesth 2019;29:77-84.
  17. Yang F, Liu Y, Yu Q, et al. Analysis of 17 948 pediatric patients undergoing procedural sedation with a combination of intranasal dexmedetomidine and ketamine. Paediatr Anaesth 2019;29:85-91.
  18. Oriby ME. Comparison of Intranasal Dexmedetomidine and Oral Ketamine Versus Intranasal Midazolam Premedication for Children Undergoing Dental Rehabilitation.Anesth Pain Med 2019;9:e85227.
  19. Moher D, Liberati A, et.al. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA statement. PLos Med 6(6): e1000097. Doi:10.1371/journal.pmed1000097
  20. Bhat R, Santhosh MC, Annigeri VM, Rao RP. Comparison of intranasal dexmedetomidine and dexmedetomidine-ketamine for premedication in pediatrics patients: A randomized double-blind study. Anesth Essays Res. 2016 May-Aug;10(2):349-55.
  21. Aly AA. A Comparison of intranasal ketamine, intranasal dexmedetomidine, and their combination as premeication in pediatric patients undergoing cardiac catheterization. Res Opin Anesth Intensive Care. 2020;7:232-40.
  22. Qian B, Zheng W, Shi J, Chen Z, Guo Y, Yao Y. Ketamine Enhances Intranasal Dexmedetomidine-Induced Sedation in Children: A Randomized Double- Blind Trial. Drug Des Devel and Ther. 2020;14:3559-65.
  23. Sado-Filho J, Correa-Faria P,  et al. Dexmedetomidine compared to a Combination of Intranasal Dexmedetomidine with Ketamine for Sedation of Children Requiring Dental Treatment: A Randomized Clinical Trial. Journal of Clinical Medicine 2021;10:2840.
  24. Lu X, Tang L, Lan H, Li C, Lin H. A Comparison of Intranasal Dexmedetomidine, Esketamine or a Dexmedetomidine-Esketamine Combination for Induction of Anaesthesia in Children: A Randomized Controlled Double-Blind Trial. Frontiers in Pharmacology 2021;12:808930.
  25. Sun M, Liu H, Yu, Q, Liu Y, Zhang J, Lei, Y, et al. A Comparison of Intranasal Dexmedetomidine and Dexmedetomidine-Ketamine Combination Sedation for Transthoracic Echocradiography in Pediatric Patients with Congenital Heart Disease: A Randomized Controlled Trial. Cardiothorac Vasc  Anesth 2020;000:1-6.
  26. Mahmoud M, Mason KP. Dexmedetomidine: review, update, and future considerations of paediatric perioperative and periprocedural applications and limitations. Br J Anaesth. 2015; 115: 171-182.
  27. Hsu YW, Cortinez LI, Robertson KM, et al. Dexmedetomidine pharmacodynamics: Part I: crossover comparison of the respiratory effects of dexmedetomidine and remifentanil in healthy volunteers. Anesthesiology. 2004; 101: 1066-1076.
  28. Hammer GB, Drover DR, Cao H, et al. The effects of dexmedetomidine on cardiac elec- trophysiology in children. Anesth Analg. 2008; 106: 79-83.
  29. Yuen VM, Hui TW, Irwin MG, Yuen MK. A comparison of intranasal dexmedetomidine and oral midazolam for premedication in paediatric anaesthesia: A double-blinded randomized controlled trial. Anesth Analg. 2008;106:1715–21.
  30. Yuen VM, Hui TW, Irwin MG, Yao TJ, Wong GL, Yuen MK. Optimal timing for the administration of intranasal dexmedetomidine for premedication in children. Anaesthesia. 2010;65:922–9.
  31. Jaume Canet, Jorge Castillo. Ketamine: A Familiar Drug We Trust. Anesthesiology. 2012; 116: 6-8.
  32. Kurdi MS, Theerth KA, Deva RS. Ketamine: current applications in anesthesia, pain and critical care. Anesth Essays Res. 2014; 8: 283-290.
  33. Diaz JH. Intranasal ketaminepreinduction of paediatric outpatients. Paediatr Anaesth. 1997; 7: 273-278.
  34. Malinovsky JM, Servin F, Cozian A, et al. Ketamine and norketamine plasma concentrations after i.v., nasal and rectal administration in children. Br J Anaesth. 1996; 77: 203-207.
  35. Hustveit O, Maurset A, Oye I. Interaction of the chiral forms of ketamine with opioid, phencyclidine, sigma and muscarinic receptors. Pharmacol Toxicol. 1995; 77: 355-359.
  36. Kress HG. Actions of ketamine not related to NMDA and opiate receptors. Anaesthesist. 1994; 43: 15-24.
  37. Zanaty OM, El Metainy SA. A comparative evaluation of nebulized dexmedetomidine, nebulized ketamine, and their combination as premedication for outpatient pediatric dental surgery. Anesth Analg. 2015 Jul;121(1):167-171.
  38. Qiao H, Xie Z, Jia J. Pediatric premedication: a double-blind randomized trial of dexmedetomidine or ketamine alone versus a combination of dexmedetomidine and ketamine. BMC Anesthesiol. 2017 Nov 29;17(1):158.
  39. Tai J, Han M, Lee D, Park IH, Lee SH, Kim TH. Different Methods and Formulations of Drugs and Vaccines for Nasal Administration. Pharmaceutics. 2022 May 17;14(5):1073.
  40. ST Verghese & RS Hannallah (2008) Anesthesia for non-cardiac surgery in children with congenital heart disease, Southern African Journal of Anaesthesia and Analgesia, 14:1, 84-86,
  41. Tobias JD, Berkenbosch JW. Initial experience with dexmedetomidine in paediatric-aged patients. Pediatric Anesthesia 2002;  12:  171–5.
  42. Tazeroualti N, De Groote F, De Hert S, De Villé A, Dierick A, Van der Linden P. Oral clonidine vs midazolam in the prevention of sevoflurane-induced agitation in children. A prospective, randomized, controlled trial. Br J Anaesth. 2007;98:667–71
  43. Kim J, Kim SY, Lee JH, Kang YR, Koo BN. Low-dose dexmedetomidine reduces emergence agitation after desflurane anaesthesia in children undergoing strabismus surgery. Yonsei Med J. 2014;55:508–16.
  44. Vutskits L, Sall JW. Reproducibility of science and developmental anaesthesia neurotoxicity: a tale of two cities. Br J Anaesth. 2017; 119: 451-452.
  45. Duan X, Li Y, Zhou C, et al. Dexmedeto- midine provides neuroprotection: impact on ketamine-induced neuroapoptosis in the developing rat brain. Acta Anaesthesiol Scand. 2014; 58: 1121-1126.

Tools


Copyright © 2024  KITE Digital Educational Solutions |  Exclusively distributed by CE-Logic